CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 348 enrolled
Drug / intervention
AKL-T01 +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02674633
NCT02674633N/ACompleted

A Randomized, Controlled, Parallel-group, Intervention Study to Assess At-home, Game-based Digital Therapy for Treating Pediatric Participants Ages 8 to 12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)

Akili Interactive Labs, Inc.·interventional·Posted Feb 4, 2016·Updated Aug 14, 2020

In Brief

A clinical study evaluating AKL-T01 and AKL-T09 for Attention Deficit Disorder With Hyperactivity. Completed, enrolled 348 participants across 20 sites.

Detailed Summary

The purpose of this study is to evaluate the effects of videogame-like digital therapies on attentional functioning and symptoms in children diagnosed with ADHD.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedFeb 4, 2016
Enrollment StartMay 1, 2016
Primary CompletionJul 31, 2017
Study CompletionAug 31, 2017
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 10.4 years ago

Interventions

AKL-T01device

Videogame-like digital therapy

AKL-T09device

Videogame-like digital therapy